A multicenter comparison of methods for typing strains of pseudomonas aeruginosa predominantly from patients with cystic fibrosis

Journal of Infectious Diseases

Volumn 169, Issue 1, 1994, Pages 134-142

  Spcert, David P ^a   Johnson, Zaiga ^e   Puterman, Martin L ^a   John, Govan ^b   Doherty, Catherine ^b   Høiby, Niels ^c   Ojeniyi, Bente ^c   Lam, Joseph S ^d   Ogle, John W ^e   Paranchych, William ^f   Sastry, P A ^f   Pitt, Tyrone L ^g   Linda, Lawrance ^g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b University of Edinbur   (United Kingdom)

^c Statens Seruminstitut ^*  (United States)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; BACTERIUM LIPOPOLYSACCHARIDE; PSEUDOMONAS EXOTOXIN;

ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPE; STRAIN DIFFERENCE;

AGGLUTINATION TESTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; BACTERIOPHAGE TYPING; BASE SEQUENCE; COMPARATIVE STUDY; CYSTIC FIBROSIS; EVALUATION STUDIES; EXOTOXINS; FIMBRIAE PROTEINS; GENES, BACTERIAL; HUMAN; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027958417     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.1.134     Document Type: Article

References (36)

1. Laraya-Cuasay LR, Cundy KR, Huang NN. Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families. J Pediatr 1976;89:23-6.
2. Hoogkamp-Korstanje J AA, van der Laag J. Incidence and risk of cross colonization in cystic fibrosis holiday camps. Antonie van Leeuwenhoek 1980;46:100-1.
3. Speert DP, Lawton D, Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J Pediatr 1982;101:227-9.
4. Kelly NM, Fitzgerald MX, Tempany E, O'Boyle C, Fatkiner FR, Keane CT. Does Pseudomonas cross-infection occur between cystic fibrosis patients? Lancet 1982;2:688-90.
5. Zimakoff J, Hoiby N, Rosendal K, Guilbert JP. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J Hosp Infect 1983;4:31-40.
6. Thomassen MJ. Demko CA. Doershuk CF. Root JM. Pseudomonasaeruginosa isolates: Comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol 1985;1:40-5.
7. Pedersen SS. Koch C. Hoiby N. Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 1986:17:505-16.
8. Speert DP. Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect 1987:9:11-21.
9. Grothues D, Koopmann U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988:26:1973-7.
10. Haiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989;78:395-404.
11. Bergan T. Phage typing of Pseudomonas aeruginosa.In: Bergan T. Norris JR. eds. Methods in microbiology. 10th ed. London: Academic Press, 1978:169-99.
12. Pitt TL. State of the art: Typing Pseudomonas aeruginosa.J Hosp Infect 1980:1:193-9.
13. Pitt TL. A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa.J Med Microbiol 1981:14:261-70.
14. Ojeniyi B. Haiby N. Rosdahl VT. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa.APMIS 1991;99:492-8.
15. Ojeniyi B. Hoiby N. Comparison of different typing methods of Pseudomonas aeruginosa.Antibiot Chemother 1991:44:13-22.
16. Hoi by N, Rosendal K. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol Microbiol Scand [B] 1980;88:125-31.
17. Hancock REW. Mutharia LM, Chan L, Darveau RP. Speert DP, Pier GB. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypable strains deficient in lipopoly-saccharide O side chains. Infect Immun 1983;42:170-7.
18. Ojeniyi B, Lam JS, Hoiby N, Rosdahl VT. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies. APMIS 1989;97:631-6.
19. Ojeniyi B. Wolz C. Doring G, Lam JS, Rosdahl VT, Hoiby N. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 1990:98:423-31.
20. Ogle JW, Janda JM, Woods DE, Vasil ML. Characterization and use of a DN A probe as an epidemiological marker for Pseudomonas aeruginosa.J Infect Dis 1987:155:1 19-26.
21. Speert DP, Campbell ME, Farmer SW, Volpel K, Joffe AM, Paran-chych W. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.J Clin Microbiol 1989;27:2589-93.
22. Campbell ME, Farmer SW, Speert DP. A new selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9, 10-dihydro-10-phenylacridine (C-390). J Clin Microbiol 1988;26:1910-2.
23. Lam JS, MacDonald LA, Lam MYC, Duchesne LGM, Southam GG. Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.Infect Immun 1987;55: 1051-7.
24. Lam JS, MacDonald LA, Lam MYC. Production of monoclonal anti bodies against serotype strains of Pseudomonas aeruginosa.Infect Immun 1987:55:2854-6.
25. Liu PV, Wang S. Three new major somatic antigens of Pseudomonasaeruginosa.J Clin Microbiol 1990;28:922-5.
26. Mikkelsen OS. Serotyping of Pseudomonas aeruginosa 1. Study on the production of anti O sera. Acta Pathol Microbiol Scand [B] 1968:73:373-90.
27. Mikkelsen OS. Serotyping of Pseudomonas aeruginosa 2. Results of an O group classification. Acta Pathol Microbiol Scand [B] 1970;78: 163-75.
28. Asheshov EH. An assessment of the methods used for typing strains of Pseudomonas aeruginosa.In: Arseni A, ed. Proceedings of the 6th National Congress of Bacteriology. Athens: Leontiadi Medical Editions, 1974:9-22.
29. Fyfe JAM, Harris G, Govan JRW. Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol 1984;20:47-50.
30. Coleman K, Dougan G, Arbuthnott JP. Cloningandexpression in Escherichia eoli KI2 of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa.J Bacteriol 1983:153:909-15.
31. Paranchych W. Molecular studies on NMePhe pili. In: Clark VL, Ig-lewski BH, eds. The bacteria. XI. Orlando. FL: Academic Press. 1990:61-78.
32. Maniatis T. Fritsch EF. Sambrook J. Molecular cloning: A laboratory manual. Cold Spring Harbor. NY: Cold Spring Harbor Press, 1982.
33. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sei USA 1977;74:5463-7.
34. Vasil M. Chamberlain C. Grant C. Molecular studies of Pseudomonasexotoxin A gene. Infect Immun 1986;52:538-48.
35. Piegorsch WW. Multiple comparisons for analyzing dichotomous response. Biometrics 1991;47:45-52.
36. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986:51:873-84.